2021
DOI: 10.3390/diagnostics11071218
|View full text |Cite
|
Sign up to set email alerts
|

Mild Clinical Presentation of Joubert Syndrome in a Male Adult Carrying Biallelic MKS1 Truncating Variants

Abstract: Pathogenic variants in the MKS1 gene are responsible for a ciliopathy with a wide spectrum of clinical manifestations ranging from Meckel and Joubert syndrome (JBTS) to Bardet-Biedl syndrome, and involving the central nervous system, liver, kidney, skeleton, and retina. We report a 39-year-old male individual presenting with isolated Retinitis Pigmentosa (RP), as assessed by full ophthalmological evaluation including Best-Corrected Visual Acuity measurements, fundus examination, Goldmann Visual Field test, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…Yet, there is still a long way to go in our understanding of this complex disorder and several aspects still remain unexplained, deeply challenging genotype–phenotype correlates. For instance, while usually complete loss of function of RPGRIP1L or MKS1 causes a lethal MKS phenotype, rare biallelic truncating variants in these genes have been reported in living patients with JS (Brancati et al, 2008; Brunetti‐Pierri et al, 2021; Romani et al, 2014a; Romani et al, 2014b). Moreover, both missense and truncating variants affecting the entire length of CPLANE1 have been found in patients with either exclusively neurological JS phenotype or severe/lethal OFD6 phenotypes (Lopez et al, 2014; Romani et al, 2015); similarly, pathogenic variants in CEP290 and TMEM231 have been associated to a large spectrum of ciliopathies even within the same family, without clear genotype–phenotype correlation (Coppieters, Lefever, Leroy, & De Baere, 2010; Maglic et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Yet, there is still a long way to go in our understanding of this complex disorder and several aspects still remain unexplained, deeply challenging genotype–phenotype correlates. For instance, while usually complete loss of function of RPGRIP1L or MKS1 causes a lethal MKS phenotype, rare biallelic truncating variants in these genes have been reported in living patients with JS (Brancati et al, 2008; Brunetti‐Pierri et al, 2021; Romani et al, 2014a; Romani et al, 2014b). Moreover, both missense and truncating variants affecting the entire length of CPLANE1 have been found in patients with either exclusively neurological JS phenotype or severe/lethal OFD6 phenotypes (Lopez et al, 2014; Romani et al, 2015); similarly, pathogenic variants in CEP290 and TMEM231 have been associated to a large spectrum of ciliopathies even within the same family, without clear genotype–phenotype correlation (Coppieters, Lefever, Leroy, & De Baere, 2010; Maglic et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…To establish whether a genotype could explain the disease, we assessed the concordance with the inheritance mode, available segregation results and, most importantly, the clinical phenotype. A total of 15 cases (out of 2036) were clinically reconsidered and reclassified after genetic testing: 6 cases with a non-RP diagnosis and mutations in ABCA4, CRB1 , NRL , RLBP1, PRPF6 , RPGR were reclassified as RP, whereas 9 RP cases were revised as non-RP (3 cases with mutations in NR2E3 and CHM ) or as syndromic IRD forms (6 cases with mutations in SMARCA4 , AHI1 , CLN3, PCYT1A, MFN2 and MKS1 57 ). Therefore, the integrative management of IRD patients should avail the combined expertise of clinicians and ophthalmic geneticists.…”
Section: Discussionmentioning
confidence: 99%
“…[7] Genetic testing is widely used in the diagnosis of JS and has the potential to become a diagnostic gold standard in some atypical cases. [8] Here we report an atypical JS case presenting with gait disturbance and bilateral peroneal neuropathies.…”
Section: This Study Was Supported By National Research Foundation Of ...mentioning
confidence: 91%
“…[7] Genetic testing is widely used in the diagnosis of JS and has the potential to become a diagnostic gold standard in some atypical cases. [8]…”
Section: Introductionmentioning
confidence: 99%